- Home
- LEXX vs NYC Comparison
LEXX vs NYC Comparison
Compare LEXX & NYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEXX
- NYC
- Stock Information
- Founded
- LEXX 2004
- NYC 2013
- Country
- LEXX Canada
- NYC United States
- Employees
- LEXX N/A
- NYC N/A
- Industry
- LEXX Biotechnology: Pharmaceutical Preparations
- NYC Real Estate
- Sector
- LEXX Health Care
- NYC Finance
- Exchange
- LEXX Nasdaq
- NYC Nasdaq
- Market Cap
- LEXX 25.8M
- NYC 27.6M
- IPO Year
- LEXX N/A
- NYC N/A
- Fundamental
- Price
- LEXX $1.45
- NYC $9.96
- Analyst Decision
- LEXX Strong Buy
- NYC
- Analyst Count
- LEXX 1
- NYC 0
- Target Price
- LEXX $7.00
- NYC N/A
- AVG Volume (30 Days)
- LEXX 128.9K
- NYC 8.2K
- Earning Date
- LEXX 04-08-2025
- NYC 03-19-2025
- Dividend Yield
- LEXX N/A
- NYC N/A
- EPS Growth
- LEXX N/A
- NYC N/A
- EPS
- LEXX N/A
- NYC N/A
- Revenue
- LEXX $496,923.00
- NYC $62,060,000.00
- Revenue This Year
- LEXX $30.72
- NYC N/A
- Revenue Next Year
- LEXX $31.85
- NYC $3.18
- P/E Ratio
- LEXX N/A
- NYC N/A
- Revenue Growth
- LEXX 77.63
- NYC N/A
- 52 Week Low
- LEXX $1.15
- NYC $5.46
- 52 Week High
- LEXX $6.85
- NYC $12.52
- Technical
- Relative Strength Index (RSI)
- LEXX 43.81
- NYC 45.35
- Support Level
- LEXX $1.15
- NYC $9.75
- Resistance Level
- LEXX $1.44
- NYC $11.36
- Average True Range (ATR)
- LEXX 0.14
- NYC 0.62
- MACD
- LEXX 0.01
- NYC -0.14
- Stochastic Oscillator
- LEXX 58.82
- NYC 9.59
About LEXX Lexaria Bioscience Corp.
Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.
About NYC American Strategic Investment Co.
American Strategic Investment Co is an externally managed company that currently owns a portfolio of commercial real estate located within the five boroughs of New York City, majorly Manhattan. The Company's real estate assets consist of office properties and certain real estate assets that accompany office properties, including retail spaces and amenities.